☰

Andriy Marusyk, Ph.D. - Publications

Affiliations: 
2006 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Thomas F, DeGregori J, Marusyk A, Dujon AM, Ujvari B, Capp JP, Gatenby R, Nedelcu AM. A new perspective on tumor progression: Evolution via selection for function. Evolution, Medicine, and Public Health. 12: 172-177. PMID 39364294 DOI: 10.1093/emph/eoae021  0.558
2024 Hu Q, Remsing Rix LL, Desai B, Miroshnychenko D, Li X, Welsh EA, Fang B, Wright GM, Chaudhary N, Kroeger JL, Doebele RC, Koomen JM, Haura EB, Marusyk A, Rix U. Cancer-associated fibroblasts confer ALK inhibitor resistance in -driven lung cancer via concurrent integrin and MET signaling. Biorxiv : the Preprint Server For Biology. PMID 39253447 DOI: 10.1101/2024.08.27.609975  0.348
2023 Miroshnychenko D, Miti T, Kumar P, Miller A, Laurie M, Giraldo N, Bui MM, Altrock PM, Basanta D, Marusyk A. Stroma-mediated breast cancer cell proliferation indirectly drives chemoresistance by accelerating tumor recovery between chemotherapy cycles. Cancer Research. PMID 37791818 DOI: 10.1158/0008-5472.CAN-23-0398  0.336
2023 Capp JP, Thomas F, Marusyk A, M Dujon A, Tissot S, Gatenby R, Roche B, Ujvari B, DeGregori J, Brown JS, Nedelcu AM. The paradox of cooperation among selfish cancer cells. Evolutionary Applications. 16: 1239-1256. PMID 37492150 DOI: 10.1111/eva.13571  0.623
2023 Miroshnychenko D, Miti T, Miller A, Kumar P, Laurie M, Bui MM, Altrock PM, Basanta D, Marusyk A. Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles. Biorxiv : the Preprint Server For Biology. PMID 36798328 DOI: 10.1101/2023.02.07.527543  0.315
2022 Somarelli JA, DeGregori J, Gerlinger M, Heng HH, Marusyk A, Welch DR, Laukien FH. Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes. Medical Oncology (Northwood, London, England). 39: 137. PMID 35781581 DOI: 10.1007/s12032-022-01721-z  0.572
2021 Dujon AM, Aktipis A, Alix-Panabières C, Amend SR, Boddy AM, Brown JS, Capp JP, DeGregori J, Ewald P, Gatenby R, Gerlinger M, Giraudeau M, Hamede RK, Hansen E, Kareva I, ... ... Marusyk A, et al. Identifying key questions in the ecology and evolution of cancer. Evolutionary Applications. 14: 877-892. PMID 33897809 DOI: 10.1111/eva.13190  0.556
2021 Capp JP, DeGregori J, Nedelcu AM, Dujon AM, Boutry J, Pujol P, Alix-Panabières C, Hamede R, Roche B, Ujvari B, Marusyk A, Gatenby R, Thomas F. Group phenotypic composition in cancer. Elife. 10. PMID 33784238 DOI: 10.7554/eLife.63518  0.534
2021 Miroshnychenko D, Baratchart E, Ferrall-Fairbanks MC, Velde RV, Laurie MA, Bui MM, Tan AC, Altrock PM, Basanta D, Marusyk A. Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations. Nature Ecology & Evolution. PMID 33462489 DOI: 10.1038/s41559-020-01367-y  0.369
2021 Edwards J, Marusyk A, Basanta D. Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growth. Iscience. 24: 101901. PMID 33364589 DOI: 10.1016/j.isci.2020.101901  0.319
2020 Damaghi M, Mori H, Byrne S, Xu L, Chen T, Johnson J, Gallant ND, Marusyk A, Borowsky AD, Gillies RJ. Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve. Evolutionary Applications. 13: 2689-2703. PMID 33294017 DOI: 10.1111/Eva.13075  0.449
2020 Vander Velde R, Yoon N, Marusyk V, Durmaz A, Dhawan A, Miroshnychenko D, Lozano-Peral D, Desai B, Balynska O, Poleszhuk J, Kenian L, Teng M, Abazeed M, Mian O, Tan AC, ... ... Marusyk A, et al. Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures. Nature Communications. 11: 2393. PMID 32409712 DOI: 10.1038/S41467-020-16212-W  0.353
2020 Marusyk A, Janiszewska M, Polyak K. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance. Cancer Cell. 37: 471-484. PMID 32289271 DOI: 10.1016/J.Ccell.2020.03.007  0.336
2020 Remsing Rix L, Sumi N, Bryant A, Desai B, Li X, Welsh E, Fang B, Kuenzi B, Antonia S, Lovly C, Koomen J, Marusyk A, Haura E, Rix U. B40 IGF-Binding Protein-Mediated Sensitization of EGFR-Mutant NSCLC Cells to Osimertinib by Cancer-Associated Fibroblast Journal of Thoracic Oncology. 15: S38. DOI: 10.1016/J.Jtho.2019.12.104  0.368
2019 Janiszewska M, Tabassum DP, Castaño Z, Cristea S, Yamamoto KN, Kingston NL, Murphy KC, Shu S, Harper NW, Del Alcazar CG, Alečković M, Ekram MB, Cohen O, Kwak M, Qin Y, ... ... Marusyk A, et al. Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments. Nature Cell Biology. 21: 879-888. PMID 31263265 DOI: 10.1038/S41556-019-0346-X  0.378
2019 Peluffo G, Subedee A, Harper NW, Kingston N, Jovanović B, Flores F, Stevens LE, Beca F, Trinh A, Reddy Chilamakuri CS, Papachristou EK, Murphy K, Su Y, Marusyk A, D'Santos CS, et al. EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis. Cancer Research. PMID 31239270 DOI: 10.1158/0008-5472.Can-18-3264  0.386
2019 Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth D, Jarrett AM, Lima EABDF, Oden J, Biros G, Yankeelov TE, Curtius K, Bakir IA, Wodarz D, ... ... Marusyk A, et al. The 2019 Mathematical Oncology Roadmap. Physical Biology. PMID 30991381 DOI: 10.1088/1478-3975/Ab1A09  0.333
2019 Kaznatcheev A, Peacock J, Basanta D, Marusyk A, Scott JG. Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer. Nature Ecology & Evolution. PMID 30778184 DOI: 10.1038/S41559-018-0768-Z  0.398
2019 Rix LLR, Sumi NJ, Bryant AT, Li X, Welsh EA, Fang B, Kuenzi BM, Antonia SJ, Marusyk A, Lovly CM, Koomen JM, Haura EB, Rix U. Abstract C110: Cancer associated fibroblast-derived IGF-binding proteins augment osimertinib activity in EGFR-mutant NSCLC cells Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C110  0.417
2018 Taylor-King JP, Baratchart E, Dhawan A, Coker EA, Rye IH, Russnes H, Chapman SJ, Basanta D, Marusyk A. Simulated ablation for detection of cells impacting paracrine signalling in histology analysis. Mathematical Medicine and Biology : a Journal of the Ima. PMID 29452382 DOI: 10.1093/Imammb/Dqx022  0.401
2018 Janiszewska M, Tabassum DP, Marusyk A, Ekram MB, Castaño Z, Kingston NL, Qin Y, Laszewski T, Kwak M, Nakamura K, Fan R, Michor F, McAllister SS, Polyak K. Abstract PR02: Minor clones can drive polyclonal metastasis by affecting immune microenvironment Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-Pr02  0.431
2017 Dhawan A, Nichol D, Kinose F, Abazeed ME, Marusyk A, Haura EB, Scott JG. Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer. Scientific Reports. 7: 1232. PMID 28450729 DOI: 10.1038/S41598-017-00791-8  0.365
2017 Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, Cassani R, Cameron LA, Ficarro SB, Marto JA, Klawitter J, Brown M. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 28242709 DOI: 10.1073/Pnas.1615015114  0.337
2017 Scott J, Marusyk A. Somatic clonal evolution: A selection-centric perspective. Biochimica Et Biophysica Acta. PMID 28161395 DOI: 10.1016/J.Bbcan.2017.01.006  0.486
2016 Marusyk A, Tabassum D, Janiszewska M, Place A, Trinh A, Rozhok AI, Pyne S, Guerrierro J, Shu S, Ekram M, Ishkin A, Cahill DP, Nikolsky Y, Chan TA, Rimawi MF, et al. Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes. Cancer Research. PMID 27671678 DOI: 10.1158/0008-5472.Can-16-1457  0.452
2016 Marusyk A, Tabassum D, Guerriero J, Place A, Rozhok A, Letai A, Polyak K. Abstract B24: Targeting hyaluronan sensitizes breast cancer-associated fibroblasts to lapatinib and overcomes stromal resistance Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B24  0.471
2015 Su Y, Subedee A, Bloushtain-Qimron N, Savova V, Krzystanek M, Li L, Marusyk A, Tabassum DP, Zak A, Flacker MJ, Li M, Lin JJ, Sukumar S, Suzuki H, Long H, et al. Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer. Cell Reports. 11: 1549-63. PMID 26051943 DOI: 10.1016/J.Celrep.2015.05.011  0.421
2015 Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien E, Bhasin MK, Raimo M, Hanson SE, Marusyk A, Hematti P, Polyak K, Mariani O, Volinia S, Vincent-Salomon A, et al. Abstract P1-07-02: Mesenchymal stem cell regulated microRNAs converge on the speech gene FOXP2 and regulate breast cancer metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-02  0.387
2014 Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, et al. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell. 15: 762-74. PMID 25515522 DOI: 10.1016/J.Stem.2014.10.001  0.43
2014 Marusyk A, Tabassum DP, Altrock PM, Almendro V, Michor F, Polyak K. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature. 514: 54-8. PMID 25079331 DOI: 10.1038/Nature13556  0.372
2014 Polyak K, Marusyk A. Cancer: Clonal cooperation. Nature. 508: 52-3. PMID 24695309 DOI: 10.1038/508052A  0.398
2014 Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A, Dowsett M, et al. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Reports. 6: 514-27. PMID 24462293 DOI: 10.1016/J.Celrep.2013.12.041  0.377
2014 Chin YR, Yoshida T, Marusyk A, Beck AH, Polyak K, Toker A. Targeting Akt3 signaling in triple-negative breast cancer. Cancer Research. 74: 964-73. PMID 24335962 DOI: 10.1158/0008-5472.Can-13-2175  0.388
2013 Marusyk A, Polyak K. Cancer. Cancer cell phenotypes, in fifty shades of grey. Science (New York, N.Y.). 339: 528-9. PMID 23372002 DOI: 10.1126/Science.1234415  0.467
2013 Almendro V, Marusyk A, Polyak K. Cellular heterogeneity and molecular evolution in cancer. Annual Review of Pathology. 8: 277-302. PMID 23092187 DOI: 10.1146/Annurev-Pathol-020712-163923  0.444
2013 Almendro V, Cheng Y, Gönen M, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes H, Helland Å, Rye I, Borresen-Dale AL, Maruyama R, Oudenaarden Av, Dowsett M, et al. Abstract C47: Inference of tumor evolution during chemotherapy by computational modeling and single cell analysis of diversity. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C47  0.434
2012 Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nature Reviews. Cancer. 12: 323-34. PMID 22513401 DOI: 10.1038/Nrc3261  0.376
2012 Henry CJ, Marusyk A, Zaberezhnyy V, Casas M, Adane B, Merz A, Serkova N, DeGregori J. Abstract 4982: Aging-associated alterations in IL-7 receptor signaling and inflammation promote declining B-lymphopoiesis and increased leukemogenesis Cancer Research. 72: 4982-4982. DOI: 10.1158/1538-7445.Am2012-4982  0.685
2011 Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nature Medicine. 17: 1109-15. PMID 21822285 DOI: 10.1038/Nm.2416  0.382
2011 Henry CJ, Marusyk A, DeGregori J. Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? Aging. 3: 643-56. PMID 21765201  0.581
2011 Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. The Journal of Clinical Investigation. 121: 2723-35. PMID 21633165 DOI: 10.1172/Jci44745  0.417
2010 Henry CJ, Marusyk A, Zaberezhnyy V, Adane B, DeGregori J. Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 21713-8. PMID 21098275 DOI: 10.1073/Pnas.1005486107  0.652
2010 Fleenor CJ, Marusyk A, DeGregori J. Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle (Georgetown, Tex.). 9: 3005-11. PMID 20676038 DOI: 10.4161/Cc.9.15.12311  0.601
2010 Marusyk A, Porter CC, Zaberezhnyy V, DeGregori J. Irradiation selects for p53-deficient hematopoietic progenitors. Plos Biology. 8: e1000324. PMID 20208998 DOI: 10.1371/Journal.Pbio.1000324  0.63
2010 Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochimica Et Biophysica Acta. 1805: 105-17. PMID 19931353 DOI: 10.1016/J.Bbcan.2009.11.002  0.344
2009 Marusyk A, Casás-Selves M, Henry CJ, Zaberezhnyy V, Klawitter J, Christians U, DeGregori J. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. Cancer Research. 69: 7262-9. PMID 19738065 DOI: 10.1158/0008-5472.Can-09-0604  0.631
2008 Marusyk A, DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochimica Et Biophysica Acta. 1785: 1-11. PMID 17980163 DOI: 10.1016/J.Bbcan.2007.09.001  0.656
2007 Marusyk A, DeGregori J. Replicational stress selects for p53 mutation. Cell Cycle (Georgetown, Tex.). 6: 2148-51. PMID 17786047 DOI: 10.4161/Cc.6.17.4732  0.592
2007 Marusyk A, Wheeler LJ, Mathews CK, DeGregori J. p53 mediates senescence-like arrest induced by chronic replicational stress. Molecular and Cellular Biology. 27: 5336-51. PMID 17515610 DOI: 10.1128/Mcb.01316-06  0.575
2006 Marusyk A, DeGregori J. Building a better model of cancer. Cell Division. 1: 24. PMID 17049090 DOI: 10.1186/1747-1028-1-24  0.612
2005 Bilousova G, Marusyk A, Porter CC, Cardiff RD, DeGregori J. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. Plos Biology. 3: e401. PMID 16277552 DOI: 10.1371/Journal.Pbio.0030401  0.696
Show low-probability matches.